Reprogramming the T cell response to cancer by simultaneous, nanoparticle-mediated PD-L1 inhibition and immunogenic cell death
Journal of Controlled Release(2019)
Abstract
•A folate receptor-targeted nanoparticle was prepared for co-delivery of doxorubicin and miR-200c (DOX/miR-NPs).•The DOX/miR-NPs inhibited PD-L1 expression and robustly induced immunogenic cell death in cancer cells in vitro and in vivo.•The treatment with DOX/miR-NPs significantly increased tumor-infiltrated dendritic cells and cytotoxic T cells.•The tumor growth was remarkably inhibited by DOX/miR-NPs.
MoreTranslated text
Key words
Doxorubicin,microRNA,Folic acid,Nanoparticle,PD-L1
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined